Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: A Pilot Study on the Effects of Vaginal Testosterone Therapy

NCT01697345 is registered in ClinicalTrials.gov with Creighton University as lead sponsor.

NCT NCT01697345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01697345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: A Pilot Study on the Effects of Vaginal Testosterone Therapy
Lead sponsor
Creighton University
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2013
Completion date
May 31, 2013
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, dyspareunia, sexual health quality of life, vaginal dryness